PATENT CLAIM ANALYSIS

Application Number: 16055565
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "248100"]

Abstract:
The invention provides methods and compositions for treating fibromyalgia (FM) and chronic fatigue syndrome (CFS) in an individual. The methods provided herein entail administering a composition comprising an isolated  Mycobacterium  or antigenic fragments derived therefrom. Also provided herein are methods for assessing alleviation of symptoms and/or alteration of immune system functioning following administration of a composition comprising an isolated  Mycobacterium  or antigenic fragments derived therefrom.

Claim (Index 17):
The method of  claim 16 , wherein the elevation or increase in immune system function is evidenced by the production of T H 1 cytokines, upregulation of granzyme B or both.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 96.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11838631', '15061201', '09374142', '13761092', '13387096']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6591588124810254
- 35 USC 102 Novelty (BERT): 0.4919305941888177
- Combined Prediction Score: 0.6424359906518046
- Mean Citation Score: 199.16087
- Max Citation Score: 203.08032
- Similarity Product: 150.93717470603943

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test